STAT, June 19, 2017. Trump’s team is reportedly considering moves that would do little to address the problem — and would instead please the pharmaceutical industry.
Read More »News That Quotes Us & Our Work
We are often quoted in major newspapers and magazines, and on well-respected TV shows, radio programs, and websites where we share our opinion on issues that matter to you and your health. Stay up to date on health news and our take on it by reading the articles in this section.
Will a New FDA User Fee Discourage Medical Device Innovation?
Bloomberg BNA, June 12, 2017. De novo is a way to get products to market without going through the FDA’s most stringent review process, premarket approval.
Read More »FDA Questions Effect of Abuse-Deterrent Opioids
Behavioral Healthcare Executive, June 13, 2017. FDA aims to gather information to determine the effects of products with abuse-deterring formulations.
Read More »Misplaced Trust: Why FDA Approval Doesn’t Guarantee Drug Safety
Drugwatch, May 8, 2017. “Taxpayers are also paying for agency [funding], but we’re not treated as the customers — the companies are,” Zuckerman said.
Read More »